Trials / Terminated
TerminatedNCT05650086
Novel Thermal Imaging Technique for Breast Screening
A Phase II Study to Evaluate Accuracy of ThermalytixTM in Detecting Breast Cancer
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 115 (actual)
- Sponsor
- University of Arizona · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
This trial is to study a new breast imaging tool called Thermalytix™. ThermalytixTM is a new radiation-free, automated breast cancer screening technique that uses Artificial Intelligence (AI) over thermal images. Thermal images are heat signatures in our body. This new technique will capture heat signatures in the breast and analyze those images with AI software. This study will evaluate the performance of ThermalytixTM breast imaging against standard imaging modalities, such as mammography and ultrasound.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Thermalytix | One-time Thermal imaging is performed for this cohort. |
Timeline
- Start date
- 2022-11-15
- Primary completion
- 2023-06-30
- Completion
- 2023-06-30
- First posted
- 2022-12-14
- Last updated
- 2024-09-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05650086. Inclusion in this directory is not an endorsement.